Effects of talipexole on emesis-related changes in abdominal afferent vagal activity and ileal serotonin metabolism in rats

Research Communications in Molecular Pathology and Pharmacology

Volumn 95, Issue 1, 1997, Pages 67-82

  Minami, Masaru ^a   Nemoto, Masahiro ^a   Endo, Tom ^a   Hamaue, Naoya ^a   Kohno, Yasuko ^b  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b NIPPON BOEHRINGER INGELHEIM CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLSEROTONIN; 5 HYDROXYINDOLEACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING); BROMOCRIPTINE MESILATE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; METOCLOPRAMIDE; SEROTONIN 3 RECEPTOR; TALIPEXOLE; TRYPTOPHAN HYDROXYLASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; ILEUM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE CELL EXCITABILITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; VAGUS NERVE; VOMITING;

ABDOMEN; ANIMALS; AZEPINES; BIOGENIC MONOAMINES; BROMOCRIPTINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ILEUM; MALE; MONOAMINE OXIDASE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; SEROTONIN; TRYPTOPHAN HYDROXYLASE; VAGUS NERVE; VOMITING;

EID: 0031030354     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Andrews, P.L.R., Davis, C.J., Bingham, S., Davidson, H.I.M., Hawthorn, J. and Maskell, L. (1990). The abdorminal visceral innervation and the emetic reflex: pathways, pharmacology and plasticity. Can. J. Physiol. Pharmac. 68: 325-345.
2. Andrews, P.L.R. and Bhandari, P. (1993). The 5-hydroxytryptamine receptor antagonists as antiemetics: preclinical evaluation and mechanism of action. Eur. J. Cancer 29A: S11-S16.
3. Endo, T., Nemoto, M., Minami, M., Yoshioka, M., Saito, H. and Parvez, S.H. (1995). Changes in the afferent abdorminal vagal nerve activity induced by cisplatin and copper sulfate in the ferret. Biogenic Amines 11: 399-407.
4. Hinzen, D., Hornykiewicz, O., Kobinger, W., Pichler, L., Pifl.C. and Schignitz, G. (1986). The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment. Eur. J. Pharmacol. 131: 75-86.
5. Hsu, W.H., Schaffer, D.D. and Dyer, D.C. (1986). The emetic effect of B-HT 920 and apomorphine in the dog : antagonism by haloperidol. Life Sci. 39: 1021-1026.
6. Irifune, M., Nomoto, M. and Fukuda, T. (1993). Effects of talipexole on motor behavior in normal and MPTP-treated common marmosets. Eur. J. Pharmacol. 238: 235-240.
7. Kohno, Y., Kitamura, Y., Nakazawa, M. and Nomura, Y. (1996a). The effects of talipexole on central monoamine receptors and metabolism, with special reference to its effects on dopaminergic systems. Pharmacometrics 52: 233-241.
8. 2 receptor stimulation in cynomolgus monkeys with unilateral lesions in the ventromedial tegmentum, Eur. J. Pharmacol., in press.
9. Kuhn, D.M., Vogel, R.T. and Lovenberg, W. (1978). Calcium-dependent activation of tryptophan hydroxylase by ATP and magnesium. Biochem. Biophys. Res. Comm. 82: 759-766.
10. 14C]talipexole (1) Absorption, distribution and excretion after single administration in rats, lyakuhin Kenkyu 25: 99-110.
11. Lowry, O.H., Rosenbrough, N.J., Farr, A.L. and Randall, R.J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275.
12. Matsubayashi, H., Amano, T., Hongjiing, Y., Kohno, Y and Sasa, M. (1995). Action of intravenously administered talipexole on the rat striatal neurons receiving excitatory input from nigral dopamine neurons. Psychopharmacol. 120: 369-375.
13. Minami, M., Sano, M., Togashi, H., Sakurai, H. and Saito, H. (1988). Stroke-related plasma noradrenaline, angiotensin II, and serotonin concentrations in stroke-prone spontaneously hypertensive rats. In: Progress in Hypertension, vol. 1, Edited, by Saito, H., Parvez, H., Parve, S. and Nagatsu, T. VSP, Utrecht, The Netherlands, pp89-114.
14. Mitchelson F. (1992). Pharmacological agents affecting emesis. A review (Part I). Drugs 43: 295-315.
15. Nakanishi, T., Kowa, H., Mizuno, Y. and Yanagisawa, N. (1993). The clinical evaluation of B-HT 920 (talipexole hydrochloride) in Parkinson's disease. Clin. Eval. 21: 59-110.
16. Nemoto, M., Endo, T., Minami, M., Monma, Y., Yoshioka, M. and Saito, H. (1994). Significanse in the measurement of the afferent abdorminal vagal activity of ferrets and rats. Jpn. J. Clin. Pharmacol. Ther. 25: 61-62.
17. 3 receptor blocking properties of the antiparkinsonian agent, talipexole. Gen. Pharmacol. 27: 779-785.
18. Pinder, R.M., Brogden, R. N., Sawyer, P. R., Speight, T.M. and Avery, G.S. (1976). Metoclopramide: a review of its pharmacological properties and clinical use. Drugs 12: 81-131.
19. Sakai, K., Matsumura, R., Kohei, H., Hanawa, S., Watanabe, L., Ninomiya, S. and Esumi, Y. (1994). Studies on the metabolic fate of [14C]talipexole (IV) - Absorption, metabolism and excretion in monkeys. Iyakuhin Kenkyu 25: 134-146.
20. Schran, H.F., Tse, F.L.S. and Bhuta, S.I. (1985). Pharmacokinetics and pharmacodynamics of bromocriptine in the rat. Biopharmacuetics & Drug Disposition 6: 301-311.
21. Yanagisawa, N., Kowa, H., Mizuno, Y. and Nakanishi, T. (1992). Clinical phase II study of talipexole dihydrochloride (B-HT 920) tablet in Parkinson's disease - results of muticenter open study (Step II). Rinsho lyaku 8: 2841-2867.
22. Yoshioka, M., Ikeda, T., Abe, M., Togashi, H., Minami, M. and Saito, H. (1992). Pharmacological characterization of 5-hydroxytryptamine-induced excitation of afferent cervical vagus nerve in anaesthetized rats. Br. J. Pharmacol. 106: 544-549.